| NCT ID | NCT07536906 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr. Kerstin de Wit |
| Condition | Intracranial Bleed |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2026-05-01 |
| Primary Completion | 2029-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2026-05-01 with a primary completion date of 2029-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Each year, one in three adults over the age of 65 has a fall. These falls lead to half a million Canadian emergency department patient visits annually and falls in older adults account for more than 3% of all emergency department visits. A rapid, simple bedside test (known as a decision rule) to guide emergency physicians on when older adults should have a brain scan to diagnose traumatic brain bleeding was created. This decision rule will be checked to see if it works well in guiding who needs a brain scan.
Eligibility Criteria
Inclusion Criteria: * Age 65 or older * Present to the emergency department within 48 hours of having a fall * Fall from standing, from a chair, toilet seat, or bed Exclusion Criteria: * Transferred from another hospital organization after brain imaging * Leave the emergency department prior to completion of their medical assessment * Previously enrolled * Lives outside the hospital catchment area
Contact & Investigator
Kerstin de Wit, MD
PRINCIPAL INVESTIGATOR
Queens University
Frequently Asked Questions
Who can join the NCT07536906 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Intracranial Bleed. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07536906 currently recruiting?
Yes, NCT07536906 is actively recruiting participants. Contact the research team at natasha.clayton@queensu.ca for enrollment information.
Where is the NCT07536906 trial being conducted?
This trial is being conducted at Boston, United States, Hamilton, Canada, Kingston, Canada, Ottawa, Canada and 3 additional locations.
Who is sponsoring the NCT07536906 clinical trial?
NCT07536906 is sponsored by Dr. Kerstin de Wit. The principal investigator is Kerstin de Wit, MD at Queens University. The trial plans to enroll 4,000 participants.